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Selective high-affinity transport of aspartate by a Drosophila
homologue of the excitatory amino-acid transporters
Marie-Thérèse Besson, Laurent Soustelle and Serge Birman
Excitatory amino-acid transporters (EAATs) are
structurally related plasma membrane proteins that
mediate the high-affinity uptake of the acidic amino
acids glutamate and aspartate released at excitatory
synapses, and maintain the extracellular concentrations
of these neurotransmitters below excitotoxic levels [1–4].
Several members of the EAAT family have been
described previously. So far, all known EAATs have
been reported to transport glutamate and aspartate
with a similar affinity. Here, we report that dEAAT2 — a
nervous tissue-specific EAAT homologue that we
recently identified in the fruit fly Drosophila [5] — is a
selective Na+-dependent high-affinity aspartate
transporter (Km = 30 µM). We found that dEAAT2 can
also transport L-glutamate but with a much lower
affinity (Km = 185 µM) and a 10- to 15-fold lower relative
efficacy (Vmax/Km). Competition experiments showed
that the binding of glutamate to this transporter is
much weaker than the binding of D- or L-aspartate. As
dEAAT2 is the first known EAAT to show this substrate
selectivity, it suggests that aspartate may play a specific
role in the Drosophila nervous system. 
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Results and discussion
The acidic amino acid L-glutamate has long been known
to be involved in excitatory neurotransmission in arthro-
pods [6] and Drosophila [7]. We previously isolated two
Drosophila EAATs, dEAAT1 (also identified by Seal
et al. [8]) and dEAAT2, which show 35–45% amino-acid
identity with vertebrate EAAT sequences and have a
similar hydrophobic profile [5]. Although dEAAT1 and
dEAAT2 are both specifically expressed in the nervous
system, they have different patterns of cellular expres-
sion [5]. The pattern of expression of dEAAT1 and
dEAAT2 in the Drosophila embryonic central nervous
system (CNS) is shown in Figure 1; dEAAT1 is
expressed in several rows of cells, whereas a smaller
number of apparently distinct cells (4–6 per hemiseg-
ment) express dEAAT2 in the nerve cord. 
All known vertebrate EAAT proteins transport L-gluta-
mate and D- or L-aspartate with high affinity, and this
active transport is driven by the Na+/K+ electrochemical
gradient. Likewise, in insects, Drosophila dEAAT1 and the
closely related (59% amino-acid identity) TrnEAAT1 from
the caterpillar Trichoplusia ni have been found to transport
both glutamate and aspartate with high affinity [8,9]. The
Drosophila EAATs, dEAAT1 and dEAAT2, are distantly
related and show only 36% identity at the amino-acid
level. To characterise the transport properties of dEAAT2,
we transiently transfected the dEAAT1 and dEAAT2
cDNAs into Drosophila Schneider S2 cells. S2 cells do not
endogenously express either dEAAT1 or dEAAT2, as
assayed by reverse transcription PCR (data not shown). In
addition, a significant uptake of D-aspartate in untrans-
fected S2 cells was detected only at millimolar substrate
concentration, which shows that these cells do not have
an endogenous high-affinity transport system for excita-
tory amino acids. Figure 1a (right panel) shows that, at a
substrate concentration of 1 µM, the uptake of either
L-glutamate or the non-metabolisable substrate analogue
D-aspartate is significantly enhanced in S2 cells transiently
transfected with the dEAAT1 cDNA. This result confirms
the data obtained in COS-7 cells with dEAAT1 [8] and
shows that S2 cells are suitable for studying excitatory
amino acid transport. By contrast, although D-aspartate
transport was enhanced in a similar way in S2 cells trans-
fected with the dEAAT2 cDNA, these cells did not show
any significant transport of L-glutamate at 1 µM as com-
pared with the untransfected cells (Figure 1b, right panel).
These results show that the two Drosophila EAATs differ
strikingly in their substrate discrimination. 
To further characterise the transport mediated by
dEAAT2, we isolated a polyclonal S2 cell line that stably
expresses dEAAT2. Uptake experiments with these cells
confirmed the results of the transient expression studies.
At a substrate concentration of 1 µM, the dEAAT2-
expressing cells transported L-aspartate and D-aspartate;
transport of L-glutamate was not significant (Figure 2a).
Uptake by dEAAT2 was found to be linear with time up to
10 minutes at 1 µM D-aspartate and up to 2 minutes at
1 mM D-aspartate (data not shown). The kinetic para-
meters were therefore determined after 2 minutes of
uptake. We observed that dEAAT2 can transport L-gluta-
mate but less efficiently and with a much lower affinity
(Figure 2b). The kinetic data fitted well with the Michaelis
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function. Comparable Km values in the 15–45 µM range
were obtained with D-aspartate and L-aspartate (Figure 2b
and Table 1), indicating a high affinity, whereas the Km
value obtained with L-glutamate was much higher, around
185 µM. As the Vmax is also higher with aspartate than with
L-glutamate, the relative efficacy (Vmax/Km) of the uptake
of L-glutamate appears 10–15-fold lower than that of L- or
D-aspartate, respectively, with dEAAT2 (Table 1). For the
sake of comparison, the Km values previously published in
the case of the human transporters hEAAT1 and hEAAT2
were 60 µM and 54 µM, respectively, with aspartate and 45
and 66 µM with L-glutamate [3]. 
Next, we compared the inhibitory effects of an excess of
unlabelled stereoisomers of aspartate or glutamate on the
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Table 1
Kinetic parameters of excitatory amino-acid uptake by dEAAT2.
Substrate Km (µM) Vmax (pmol/min/mg) Vmax/Km
L-Asp 33.7 ± 6.2 149.7 ± 21.4 4.6 ± 0.7
D-Asp 29.2 ± 6.1 178.0 ± 38.6 7.1 ± 2.1
L-Glu 184.9 ± 12.4 88.2 ± 6.8 0.47 ± 0.03
Michaelis–Menten parameters were determined from the dose-response
curves generated by least-square fitting with data obtained at 1–250 µM
amino-acid substrates. Results represent the mean ± SE of four (D-Asp)
or three (L-Asp and L-Glu) independent determinations with each
substrate, in which the curve fits had a correlation coefficient superior to
0.95 (see Figure 2b). The differences between the values obtained with
L-Asp or, respectively, D-Asp and L-Glu are statistically significant as
determined by the non-parametric Mann–Whitney test (p < 0.05). 
Figure 2
Substrate discrimination of dEAAT2-mediated transport.
(a) L-[3H]-glutamate (L-Glu), L-[3H]-aspartate (L-Asp) and D-[3H]-aspartate
(D-Asp) uptake into a S2 polyclonal cell line stably transfected with the
dEAAT2 expression vector. Transport was measured under standard
conditions in the presence of 1 µM amino-acid substrate as indicated.
White bars, untransfected S2 cells; grey bars, dEAAT2-expressing
cells. Similar results were obtained in five independent experiments with
L-glutamate and D-aspartate and three independent experiments with
L-aspartate. (b) Dose-response curves for excitatory amino-acid uptake
into dEAAT2-expressing S2 cells. The curves were obtained by fitting the
Michaelis–Menten function to the data with the least-square method. Filled
circles, D-aspartate; unshaded circles, L-aspartate; unshaded squares,
L-glutamate. Each datum is the mean ± SE of triplicate determinations.
In these experiments, the Km values determined with D-aspartate,
L-aspartate and L-glutamate were 15.3, 45.7 and 190.3 µM, respectively,
and the Vmax values were 162.4, 186.5 and 80.4 pmol/min/mg. 
Figure 1
Comparison of the embryonic CNS expression pattern and transport
properties of Drosophila EAATs. Left panels, ventral view of
Drosophila embryos stained by whole mount in situ hybridisation with
an antisense (a) dEAAT1 or (b) dEAAT2 RNA probe. Note the
differential expression of dEAAT1 and dEAAT2 in the embryonic nerve
cord. Anterior is at the top. The scale bars represent 50 µm. Right
panels, L-[3H]-glutamate (L-Glu) and D-[3H]-aspartate (D-Asp) uptake
into Drosophila S2 cells transiently transfected with (a) dEAAT1 or
(b) dEAAT2 cDNAs. S2 cells were either transfected with a mock
plasmid (control, white bars) or with the Drosophila EAAT expression
vectors (grey bars). After 24 h, transport was measured under
standard conditions (see Materials and methods) in the presence of
1 µM L-[3H]-glutamate or D-[3H]-aspartate, as indicated (exactly 1.15
and 1.08 µM, respectively, see Materials and methods). Each value is
the mean ± SE of triplicate determinations. Identical results were
obtained in three independent transient expression experiments. 
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uptake of radiolabelled D-aspartate by dEAAT2. As was to
be expected, the uptake of 1 µM radiolabelled D-aspartate
by dEAAT2 was inhibited in much the same way by excess
D- or L-aspartate (Figure 3a), which further demonstrates
that dEAAT2-mediated uptake shows little discrimination
between the D- and L-isomers of aspartate. By contrast,
L-glutamate up to 100 µM and D-glutamate up to 1 mM did
not compete for the transport of 1 µM D-aspartate.
Figure 3b shows that only a large excess of L-glutamate
(1 mM) was able to compete significantly. So L-glutamate is
apparently much less efficient than L-aspartate in inhibit-
ing the uptake of 1 µM D-aspartate by dEAAT2. These
results suggest that a low binding affinity for glutamate is
at least partly responsible for the low efficiency of
dEAAT2 in transporting L-glutamate. We also observed
that neither L-proline, glycine nor L-cysteine, a neutral
amino acid that is a specific substrate for hEAAT3 [10], at
a concentration of 100 µM, competed with 1 µM D-aspar-
tate for uptake by dEAAT2 (data not shown). Therefore,
dEAAT2 is a high-affinity aspartate transporter that
exhibits a stricter substrate selectivity than all the other
known EAATs. This protein could be the first member of
a new subfamily of EAATs that discriminates between the
aspartate and glutamate substrates. 
Other properties of D-aspartate transport by dEAAT2 are
presented in Figure 4. The uptake depends on the pres-
ence of Na+ ions in the extracellular medium, as is gener-
ally true of EAATs (Figure 4a). Three specific competitive
inhibitors of vertebrate EAATs, namely L-trans-pyrroli-
dine-2,4-dicarboxylic acid (PDC), L(-)-threo-3-hydroxy-
aspartic acid (THA) and L-dihydrokainic acid (DHK),
were tested to determine their ability to reduce D-aspar-
tate transport by dEAAT2. All three compounds were
found to compete efficiently with the dEAAT2-mediated
uptake of D-aspartate (Figure 4b). It can be noted that two
Ser residues, which are characteristic of the GLT1/EAAT2
subtypes of transporters (Ser440 and Ser443 in rat GLT1)
and are involved in the binding of DHK [11], are con-
served at equivalent positions in dEAAT2. 
Pines et al. [12] have reported that the mutagenesis of a con-
served glutamate residue (Glu404) in rat GLT1 selectively
impaired L-glutamate transport, the efficiency of which
decreased to about 10% in comparison with the wild-type
transporter, but not D- or L-aspartate transport. This acidic
residue, which is always present at equivalent positions in
other EAAT sequences, is replaced by a neutral residue, an
isoleucine (Ile392), in dEAAT2, which suggests a possible
structural basis for the substrate selectivity of dEAAT2.
Importantly, however, glutamate binding to GLT1 was not
impaired by the mutagenesis of Glu404 [12], whereas gluta-
mate binding to dEAAT2 is very low in comparison with
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Figure 3
Competition of aspartate and glutamate isomers with 1 µM
D-[3H]-aspartate for uptake by dEAAT2. Transport into dEAAT2-expressing
S2 cells was measured in the presence of 0.15 µM D-[3H]-aspartate,
1 µM unlabelled D-aspartate plus the indicated concentrations of the
unlabelled (a) D- or L-aspartate or (b) D- or L-glutamate. Filled symbols,
D-isomers; unshaded symbols, L-isomers. Uptake is expressed as a
percentage of the mean value at 1 µM D-aspartate. Results are the
mean ± SE of data obtained in four independent experiments. 
Figure 4
Properties of aspartate transport mediated by
dEAAT2 in S2 cells. (a) Na+ ion requirements
for D-[3H]-aspartate uptake into the
dEAAT2-expressing cell line. NaCl was
replaced by equivalent osmolar amounts of
mannitol. The difference between the values at
63.5 mM and 95 mM Na+ was not statistically
significant. Similar results were obtained in two
other experiments. (b) Inhibition of
dEAAT2-mediated D-[3H]-aspartate uptake by
glutamate transporter inhibitors. Transport was
measured in the absence (control) or in the
presence of the indicated concentrations of
PDC, THA or DHK. All results are the
mean ± SE of triplicate determinations.
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aspartate binding (Figure 3). Other structural differences
must obviously be responsible for the substrate discrimina-
tion of dEAAT2. In addition, mutation of Glu404 in rat
GLT1 abolished the interaction with K+ ions and converted
the transporter into an amino-acid exchanger [13], which
suggests that dEAAT2 may be an exchanger that does not
interact with K+. However, another residue, His326, which
has been found to be necessary for the transport activity of
rat GLT1 [14], is not conserved in dEAAT2. So it may not
be reliable to assign any functional significance to a particu-
lar residue by making comparisons with data obtained on a
distantly related transporter. Further experiments are
needed to analyse the transport mechanism of dEAAT2
and the associated ionic fluxes. 
Finally, what might the physiological function of a selec-
tive high-affinity aspartate transporter be in the nervous
system? The authors of a recent report demonstrated that
aspartate can be concentrated in synaptic vesicles in verte-
brate hippocampal excitatory nerve terminals and released
by exocytosis [15]. As dEAAT2 is expressed in only a few
subsets of cells in the Drosophila embryonic nerve cord
and the peripheral nervous system, it seems unlikely that
it plays a trophic role. It is tempting to speculate that
L-aspartate may be used in some neurones as a neural sig-
nalling molecule and that dEAAT2 may be involved in
concert with dEAAT1 in transmitter recycling. Further
work is required to determine whether L-aspartate and
dEAAT2 are involved in synaptic function in the
Drosophila CNS and to what extent a selective high-affin-
ity aspartate transport process has been conserved in the
nervous system throughout the course of evolution. 
Materials and methods
Construction of the dEAAT expression vectors
The dEAAT1 and dEAAT2 cDNA fragments containing the entire open
reading frame were subcloned into the expression vector pPacPL,
downstream of the constitutive actin 5C promoter, by inserting a
2.7 kb BamHI–NotI fragment of the dEAAT1 cDNA into the polylinker
sites of the pPacPL vector, and a 2.2 kb SspI fragment of the dEAAT2
cDNA into the vector EcoRV site.
S2 cell transfection
The Drosophila Schneider S2 cell line was maintained at 25°C in
Shields and Sang M3 medium (Sigma) supplemented with 10% heat-
inactivated foetal calf serum (Gibco-BRL), 100 units/ml penicillin and
100 µg/ml streptomycin. Cells were subcultured at 25°C on 100 mm
plates in 5 ml medium. Transient transfection was carried out by per-
forming calcium phosphate precipitation with 5 µg dEAAT expression
vector or control plasmid; 24 h after the transfection, the DNA precipi-
tate was discarded. Stable transfection was obtained in a similar way
by cotransfecting 5 µg dEAAT expression vector with 1 µg pMK33
plasmid carrying a hygromycin B resistance gene. Hygromycin B
(400 µg/ml) selection was performed to establish a stably transformed
polyclonal cell line, which was isolated after about 10 weeks and main-
tained in the presence of hygromycin. 
Transport assay
A few hours before the assay, the transfected cells were harvested and
subcultured at a density of about 2 × 106 per ml in 6-well culture plates
(Falcon). The cells were washed three times in 2 ml saline solution
(96 mM NaCl, 5 mM KCl, 2.5 mM CaCl2, 1.3 mM KH2PO4, 1.2 mM
MgSO4, 10 mM glucose, 62 mM mannitol, 10 mM HEPES, pH 7.2) just
before the uptake was initiated. Under standard conditions, the uptake
was performed in 500 µl saline solution containing 1 µCi tritiated
amino-acid substrate, which corresponds to 0.15 µM D-[3H]-aspartic
acid (12.8 Ci/mmol, Amersham), 0.12 µM L-[3H]-aspartic acid
(19 Ci/mmol, NEN) or 0.08 µM L-[3H]-glutamic acid (24 Ci/mmole,
NEN), plus 1 µM of the corresponding unlabelled substrate. After a
2 min incubation at 25°C, the uptake was stopped by three 3 ml
washes with an ice-cold Na+-free saline solution. The cells were air
dried and finally disrupted in 500 µl 1 N NaOH. Aliquots were used for
radioactivity measurements and protein determination with the Lowry
method. Amino-acid transport was expressed in pmol per min per mg
protein. All uptake data are the mean ± S.E. of triplicate determinations.
Kinetic data were analysed using the least square curve fitting method
with the MacCurveFit program (Kevin Raner). Whole mount in situ
hybridization and RT–PCR were performed as previously described [5]. 
Acknowledgements
We thank Nathalie Dostatni for the S2 cells, Jay Hirsh for his comments on
the manuscript and members of our laboratory for helpful discussions. This
work was supported by grants from the Centre National de la Recherche
Scientifique and the Fondation pour la Recherche Médicale. 
References
1. Kanai Y: Family of neutral and acidic amino acid transporters:
molecular biology, physiology and medical implications. Curr Opin
Cell Biol 1997, 9:565-572.
2. Takahashi M, Billups B, Rossi D, Sarantis M, Hamann M, Attwell D:
The role of glutamate transporters in glutamate homeostasis in
the brain. J Exp Biol 1997, 200:401-409.
3. Gegelashvili G, Schousboe A: Cellular distribution and kinetic
properties of high-affinity glutamate transporters. Brain Res Bull
1998, 45:233-238.
4. Seal RP, Amara SG: Excitatory amino acid transporters: a family in
flux. Annu Rev Pharmacol Toxicol 1999, 39:431-456.
5. Besson MT, Soustelle L, Birman S: Identification and structural
characterization of two genes encoding glutamate transporter
homologues differently expressed in the nervous system of
Drosophila melanogaster. FEBS Lett 1999, 443:97-104.
6. Gerschenfeld HM: Chemical transmission in invertebrate central
nervous systems and neuromuscular junctions. Physiol Rev 1973,
53:1-119.
7. Jan LY, Jan YN: L-glutamate as an excitatory transmitter at the
Drosophila larval neuromuscular junction. J Physiol (Lond) 1976,
262:215-236.
8. Seal RP, Daniels GM, Wolfgang WJ, Forte MA, Amara SG:
Identification and characterization of a cDNA encoding a neuronal
glutamate transporter from Drosophila melanogaster. Receptors
Channels 1998, 6:51-64.
9. Donly BC, Richman A, Hawkins E, McLean H, Caveney S: Molecular
cloning and functional expression of an insect high-affinity
Na+-dependent glutamate transporter. Eur J Biochem 1997,
248:535-542.
10. Zerangue N, Kavanaugh MP: Interaction of L-cysteine with a human
excitatory amino acid transporter. J Physiol (Lond) 1996,
493:419-423.
11. Zhang Y, Kanner BI: Two serine residues of the glutamate
transporter GLT-1 are crucial for coupling the fluxes of sodium and
the neurotransmitter. Proc Natl Acad Sci USA 1999, 96:1710-1715.
12. Pines G, Zhang Y, Kanner BI: Glutamate 404 is involved in the
substrate discrimination of GLT-1, a (Na+ + K+)-coupled glutamate
transporter from rat brain. J Biol Chem 1995, 270:17093-17097.
13. Kavanaugh MP, Bendahan A, Zerangue N, Zhang Y, Kanner BI:
Mutation of an amino acid residue influencing potassium
coupling in the glutamate transporter GLT-1 induces obligate
exchange. J Biol Chem 1997, 272:1703-1708.
14. Zhang Y, Pines G, Kanner BI: Histidine 326 is critical for the
function of GLT-1, a (Na+ + K+)-coupled glutamate transporter
from rat brain. J Biol Chem 1994, 269:19573-19577.
15. Gundersen V, Chaudhry FA, Bjaalie JG, Fonnum F, Ottersen OP,
Storm-Mathisen J: Synaptic vesicular localization and exocytosis of
L-aspartate in excitatory nerve terminals: a quantitative immunogold
analysis in rat hippocampus. J Neurosci 1998, 18:6059-6070.
210 Current Biology Vol 10 No 4
bb10d52.qxd  03/01/2000  03:34  Page 210
